ISOLO

Providing medical and pharmaceutical information to patients and healthcare practitioners, namely, providing medical information regarding hemolysis and the risk of occurrence in and the treatment of certain patients undergoing human intravenous immunoglobulin therapy and providing information relating to the therapeutic properties of pharmaceuticals for the treatment of hemolysis